Universität zu Köln

Kron, Florian, Kutsch, Nadine, Kostenko, Anna, Dohle, Ines, Glossmann, Jan-Peter, Mueller, Dirk, Heimann, Sebastian M., Bahlo, Jasmin, von Bergwelt-Baildon, Michael, Eichhorst, Barbara, Wolf, Juergen, Hallek, Michael and Zander, Thomas (2017). Economic evaluation of chronic lymphocytic leukemia from a hospital management perspective. Eur. J. Haematol., 98 (2). S. 169 - 177. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0609

Full text not available from this repository.

Abstract

Objectives: Treatment of chronic lymphocytic leukemia (CLL) is currently undergoing dramatic changes. We analyzed economic risks in hospitalized patients with CLL from a management perspective. Methods: One hundred and twelve patients with CLL hospitalized in 2013 and 2014 at the University Hospital of Cologne were analyzed. To assess profit margins (PMs) per case, diagnosis-related group (DRG) reimbursement data were merged with an internal cost accounting scheme depending on age, prognostic factors, and DRG key performance indicators. Results: In 112 patients, 284 cases coded by 19 different DRG with strongly fluctuating cost revenue ratios were found with an overall negative PM of (sic)137 147. The DRG R61H was identified as the one most commonly coded (174 cases, 61.3%) with a deficit per case of (sic)814. Subanalysis demonstrated that the payments were not cost covering due to excessive length of stay and staff costs. Significant differences in PM per case concerning age, length of stay and number of operation and procedure key (OPS) codes (P < 0.05) were found. Conclusion: In our researchdriven tertiary care hospital, inpatient treatment of patients with CLL is not cost covering. This analysis demonstrates the need for novel care/reimbursement structures in CLL. From a hospital management perspective, cost revenue controlling is crucial to avoid major economic risks.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Kron, Florian UNSPECIFIED UNSPECIFIED UNSPECIFIED Kutsch, Nadine UNSPECIFIED UNSPECIFIED UNSPECIFIED Kostenko, Anna UNSPECIFIED UNSPECIFIED UNSPECIFIED Dohle, Ines UNSPECIFIED UNSPECIFIED UNSPECIFIED Glossmann, Jan-Peter UNSPECIFIED UNSPECIFIED UNSPECIFIED Mueller, Dirk UNSPECIFIED UNSPECIFIED UNSPECIFIED Heimann, Sebastian M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Bahlo, Jasmin UNSPECIFIED UNSPECIFIED UNSPECIFIED von Bergwelt-Baildon, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED Eichhorst, Barbara UNSPECIFIED UNSPECIFIED UNSPECIFIED Wolf, Juergen UNSPECIFIED UNSPECIFIED UNSPECIFIED Hallek, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED Zander, Thomas UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-241260
DOI:	10.1111/ejh.12817
Journal or Publication Title:	Eur. J. Haematol.
Volume:	98
Number:	2
Page Range:	S. 169 - 177
Date:	2017
Publisher:	WILEY-BLACKWELL
Place of Publication:	HOBOKEN
ISSN:	1600-0609
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language ACUTE MYELOID-LEUKEMIA; COST-EFFECTIVENESS; CYCLOPHOSPHAMIDE; FLUDARABINE; RITUXIMAB; ILLNESS; BURDEN; EUROPE; DRG Multiple languages Hematology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/24126